Supreme Court weighs in on Purdue Pharma's bankruptcy, with an eye toward opioid victims
WASHINGTON — The notorious family at the center of the US opioid epidemic — the Sacklers — may not have been one of the parties in today’s case before the Supreme Court, but they were featured prominently in the oral arguments.
Justices focused their questions on whether the billionaire family known for Purdue Pharma’s OxyContin has put up enough money for opioid victims, and whether the company’s settlement and immunity from future suits are justified.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.